PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum
- PMID: 18330912
- DOI: 10.1002/humu.20719
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum
Abstract
Heterozygous rare variants in the PINK1 gene, as well as in other genes causing autosomal recessive parkinsonism, have been reported both in patients and healthy controls. Their pathogenic significance is uncertain, but they have been suggested to represent risk factors to develop Parkinson disease (PD). The few large studies that assessed the frequency of PINK1 heterozygotes in cases and controls yielded controversial results, and the phenotypic spectrum is largely unknown. We retrospectively analyzed the occurrence of PINK1 heterozygous rare variants in over 1100 sporadic and familial patients of all onset ages and in 400 controls. Twenty patients and 6 controls were heterozygous, with frequencies (1.8% vs. 1.5%) not significantly different in the two groups. Clinical features of heterozygotes were indistinguishable to those of wild-type patients, with mean disease onset 10 years later than in carriers of two mutations but worse disease progression. A meta-analysis indicated that, in PINK1 heterozygotes, the PD risk is only slightly increased with a non significant odds ratio of 1.62. These findings suggest that PINK1 heterozygous rare variants play only a minor susceptibility role in the context of a multifactorial model of PD. Hence, their significance should be kept distinct from that of homozygous/compound heterozygous mutations, that cause parkinsonism inherited in a mendelian fashion.
(c) 2008 Wiley-Liss, Inc.
Similar articles
-
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.J Med Genet. 2009 Jun;46(6):375-81. doi: 10.1136/jmg.2008.063917. Epub 2009 Apr 6. J Med Genet. 2009. PMID: 19351622 Free PMC article.
-
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1.Neurobiol Aging. 2021 Jan;97:146.e1-146.e13. doi: 10.1016/j.neurobiolaging.2020.06.017. Epub 2020 Jul 2. Neurobiol Aging. 2021. PMID: 32713623
-
Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.Arch Neurol. 2008 Jun;65(6):802-8. doi: 10.1001/archneur.65.6.802. Arch Neurol. 2008. PMID: 18541801
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
-
Genetic mutations and functions of PINK1.Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review.
Cited by
-
Genetic insights into sporadic Parkinson's disease pathogenesis.Curr Genomics. 2013 Dec;14(8):486-501. doi: 10.2174/1389202914666131210195808. Curr Genomics. 2013. PMID: 24532982 Free PMC article.
-
The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials.Front Genet. 2019 Oct 31;10:1061. doi: 10.3389/fgene.2019.01061. eCollection 2019. Front Genet. 2019. PMID: 31737044 Free PMC article.
-
Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson's Disease Patients.Front Cell Neurosci. 2019 Feb 22;13:58. doi: 10.3389/fncel.2019.00058. eCollection 2019. Front Cell Neurosci. 2019. PMID: 30853899 Free PMC article.
-
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.J Med Genet. 2009 Jun;46(6):375-81. doi: 10.1136/jmg.2008.063917. Epub 2009 Apr 6. J Med Genet. 2009. PMID: 19351622 Free PMC article.
-
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.Mov Disord. 2014 Jan;29(1):41-53. doi: 10.1002/mds.25724. Epub 2013 Oct 25. Mov Disord. 2014. PMID: 24167038 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases